Skip to main content
Clinical Trials/NCT06679075
NCT06679075CompletedNot Applicable

Clinical and Radiographic Evaluation of Propolis as a Hemostatic Agent in Full Pulpotomy of Mature Permanent Molars With Irreversible Pulpitis Using Two Different Dressing Materials: A Randomized Clinical Trial

Misr International University1 site in 1 country60 target enrollmentStarted: November 1, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
60
Locations
1
Primary Endpoint
Clinical and radiographic success rate

Study Overview

Brief Summary

The goal of this randomized clinical trial is to assess the effectiveness of propolis as a hemostatic agent in full pulpotomy for mature permanent molars with irreversible pulpitis, compared to sodium hypochlorite (NaOCl). The study also compares how bioceramic putty performs compared to mineral trioxide aggregate (MTA) as pulpotomy dressing materials.

Participants will be randomly allocated into four groups (15 patients each) according to the hemostatic agent and dressing material used:

  • Propolis + bioceramic putty
  • Propolis + MTA
  • Sodium hypochlorite + bioceramic putty
  • Sodium hypochlorite + MTA Bleeding time and postoperative pain will be recorded. Clinical and radiographic success will be evaluated at 1, 3, and 6 months following treatment.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
20 Years to 45 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Participants of both genders falling within the age range of 20 to 45 years.
  • •Presence of vital mature permanent molars diagnosed as irreversible pulpitis.
  • •Confirmation of vital bleeding pulp tissue in all canals following complete pulpotomy.

Exclusion Criteria

  • •Non-vital teeth.
  • •Teeth with Immature roots.
  • •Uncontrolled pulpal bleeding persisting beyond 10 minutes post-application of sodium hypochlorite as a hemostatic agent.
  • •Insufficient bleeding post-pulp exposure, indicative of pulp degeneration.

Arms & Interventions

Propolis + Bioceramic putty

Experimental

Adult permanent molars diagnosed with irreversible pulpitis to be treated with full pulpotomy using propolis as a hemostatic agent and bioceramic putty as a dressing material.

Intervention: Full pulpotomy using propolis and bioceramic putty (Procedure)

Propolis + MTA

Experimental

Adult permanent molars diagnosed with irreversible pulpitis to be treated with full pulpotomy using propolis as a hemostatic agent and MTA as a dressing material.

Intervention: Full pulpotomy using Propolis and MTA (Procedure)

Sodium hypochlorite + bioceramic putty

Experimental

Adult permanent molars diagnosed with irreversible pulpitis to be treated with full pulpotomy using sodium hypochlorite (NaOCl) as a hemostatic agent and bioceramic putty as a dressing material.

Intervention: Full pulpotomy using sodium hypochlorite and bioceramic putty (Procedure)

Sodium hypochlorite + MTA

Active Comparator

Adult permanent molars diagnosed with irreversible pulpitis to be treated with full pulpotomy using sodium hypochlorite (NaOCl) as a hemostatic agent and MTA as a dressing material

Intervention: Full pulpotomy using sodium hypochlorite and MTA (Procedure)

Outcomes

Primary Outcomes

Clinical and radiographic success rate

Time Frame: 1, 3, 6 months

Success rate of full pulpotomy procedure using different hemostatic agents and different dressing materials using the clinical and radiographic criteria for success and failure.

Bleeding time

Time Frame: During hemostasis (0-10 minutes)

Recording the bleeding time of different participants during hemostasis.

Secondary Outcomes

  • Post-operative pain(24 hours, 3 days, 1 week)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Omar Hisham Selim

Master's Candidate in Endodontics

Misr International University

Study Sites (1)

Loading locations...

Similar Trials